|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 | |||
| C07K 16/28 | |||
| C12N 15/113 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2547363 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11710004.0 |
| Europos patento paraiškos padavimo data | 2011-02-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2011/000220 |
| Data | 2011-02-17 |
| (87) | Numeris | WO 2011/101634 |
| Data | 2011-08-25 |
| (30) | Numeris | Data | Šalis |
| 305500 P | 2010-02-17 | US |
| (72) |
MAZE, Mervyn, US
FELDMAN, Marc, GB
TERRANDO, Niccolo, US
CIBELLI, Mario, GB
MA, Daqing, GB
FERTLEMAN, Michael, GB
NANCHAHAL, Jagdeep, GB
|
| (73) |
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH,
Boundary House 91 Charterhouse Street, London EC1M 6HR,
GB
|
| (54) | METHODS OF PREVENTION OR TREATMENT OF TRIGGERED INFLAMMATORY REACTIONS USING TUMOR NECROSIS FACTOR ALPHA ANTAGONIST |
| METHODS OF PREVENTION OR TREATMENT OF TRIGGERED INFLAMMATORY REACTIONS USING TUMOR NECROSIS FACTOR ALPHA ANTAGONIST |